ライフサイエンスコーパス: cadaveric kidney

1 rom ambulatory blood pressure and receipt of cadaveric kidney.

2 ntially wait 10 or more years for a suitable cadaveric kidney.

3 the sole criterion for discarding recovered cadaveric kidneys.

4 t of the steadily expanding waiting list for cadaveric kidneys.

5 s by increasing the utilization of retrieved cadaveric kidneys.

6 equal to 5 years with 69 recipients of adult cadaveric kidneys.

7 ations based upon the single wedge biopsy of cadaveric kidneys.

8 tient and graft survival compared with adult cadaveric kidneys.

9 lantation with either A2 (n=18) or A2B (n=3) cadaveric kidneys.

10 r Organ Sharing, we identified 5446 pairs of cadaveric kidneys (10,892 allografts) in which one kidne

11 ally selects blood group O living donors and cadaveric kidney allocation is determined by need.

12 yte antibodies has not been shown to improve cadaveric kidney allograft survival in randomized, contr

13 f the current program of national sharing of cadaveric kidney allografts is of uncertain benefit, and

14 Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive t

15 Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive t

16 Recipients of first cadaveric kidney allografts were treated with tacrolimus

17 ies (induction therapy) improves survival of cadaveric kidney allografts.

18 January 1994 to December 2002, 2,597 primary cadaveric kidney-alone transplants (donor age 5-45 years

19 neys, when compared with recipients of other cadaveric kidneys, also had comparable 1- and 3-year pat

20 riteria in the current allocation policy for cadaveric kidneys, although the savings appear to be sma

21 ce (CrCl) of both discarded and transplanted cadaveric kidneys and examined their effect on graft sur

22 o quantify the effect of ESRD time on paired cadaveric kidneys and on all cadaveric kidneys compared

23 2.0-4.0 mm) were randomly placed in 14 human cadaveric kidneys and scanned with a 16-detector CT scan

24 Thirty-nine (57%) cases were with cadaveric kidneys, and 30 (43%) were with living donors.

25 for kidney transplantation, more than 10% of cadaveric kidneys are discarded each year because of mar

26 e recently been made to expand the number of cadaveric kidneys available for transplantation by using

27 abolomic profile of HMP perfusate from human cadaveric kidneys awaiting transplantation and to identi

28 prospectively the merits of an allocation of cadaveric kidneys based on broader classes of HLA antige

29 ine whether this proposal would disadvantage cadaveric kidney blood group O wait list candidates, and

30 time on paired cadaveric kidneys and on all cadaveric kidneys compared to living-donated kidneys.

31 Transplantation of better-matched cadaveric kidneys could have substantial economic advant

32 matching as a priority for the allocation of cadaveric kidneys could reduce the existing racial imbal

33 nal Transplant Database were analysed on all cadaveric kidneys donated over a 5-year period in the UK

34 Efforts to enhance cadaveric kidney donation should seek to understand and

35 arable or increased compared with CRT if the cadaveric kidney donor is much younger or with fewer HLA

36 eviewed the records of all patients who were cadaveric kidney donors in the state of Louisiana betwee

37 Cadaveric kidneys experiencing longer cold ischemia time

38 servation has greatly facilitated the use of cadaveric kidneys for transplantation but damage occurs

39 st are the primary criteria used to allocate cadaveric kidneys for transplantation in the United Stat

40 Availability of cadaveric kidneys for transplantation is far below the g

41 he policy was extended to include sharing of cadaveric kidneys for which there is a recipient with a

42 Cadaveric kidneys from brain-stem-dead donors continue t

43 Single wedge biopsy of cadaveric kidneys from donors older than 55 is currently

44 The optimal use of very young cadaveric kidneys (from donors less than 4 years old) re

45 five doses, to 260 patients receiving first cadaveric kidney grafts and immunosuppressive therapy wi

46 Since then, over 7500 cadaveric kidneys have been shipped to centers in 48 sta

47 he simplicity and success of cold storage of cadaveric kidneys have led to the infrequent use of puls

48 justment for age, race, and sex, receiving a cadaveric kidney, having an estimated glomerular filtrat

49 Retrospective review of 14 cadaveric kidneys imported for repeat PP at our center a

50 matched kidneys, we identified 3562 pairs of cadaveric kidneys in which one kidney went to an HLA-mat

51 n 1990 and 1994, our group transplanted 1067 cadaveric kidneys, including 38 from HBsAg(-)/HBcAb(+) d

52 nt cytotoxicity (CXM) in consecutive primary cadaveric kidney (K) and primary simultaneous cadaveric

53 The cohort consisted of all cadaveric kidneys (n= 3,444) with reported biopsy result

54 e impact of a CREG-based local allocation of cadaveric kidneys on 3-year Medicare payments and graft

55 ential economic effects of the allocation of cadaveric kidneys on the basis of tissue-matching criter

56 d subsequent to wait-list registration: SPK; cadaveric kidney only (CAD); living donor kidney only (L

57 The authors analyzed 202 cadaveric kidney-only recipients that underwent transpla

58 Adult cadaveric kidney recipients (n=293) received Neoral or S

59 of biopsy-proven acute rejection episodes in cadaveric kidney recipients compared with cyclosporine-b

60 2002 and August 2004, 43 dialysis dependent cadaveric kidney recipients were enrolled into a study u

61 entially transplanted blood group A2 and A2B cadaveric kidneys to B blood group waiting list candidat

62 In simulations, the assignment of cadaveric kidneys to recipients by a method that minimiz

63 cent of wait-list registrants had received a cadaveric kidney transplant by June 30, 1998.

64 ed using the United Network of Organ Sharing cadaveric kidney transplant database between 1994 to 199

65 F) occurs in 15 to 25% (range, 10 to 62%) of cadaveric kidney transplant recipients and up to 9% of l

66 reducing the incidence of acute rejection in cadaveric kidney transplant recipients in several random

67 /day is a very effective and safe regimen in cadaveric kidney transplant recipients.

68 One had received a cadaveric kidney transplant, one a simultaneous kidney-p

69 losporine in 120 patients undergoing primary cadaveric kidney transplant.

70 A 40-year-old Caucasian woman received a cadaveric kidney transplant.

71 renal disease patients who underwent either cadaveric kidney transplantation alone or simultaneous p

72 The waiting list for cadaveric kidney transplantation has continued to grow,

73 ts of only certain sets of patients awaiting cadaveric kidney transplantation unless ECDs dramaticall

74 Patients undergoing primary cadaveric kidney transplantation were followed for 1 yea

75 In cadaveric kidney transplantation, selected demographic a

76 f pravastatin on these same parameters after cadaveric kidney transplantation.

77 ary immunosuppression in patients undergoing cadaveric kidney transplantation.

78 Eleven patients underwent simultaneous cadaveric kidney transplantation.

79 ified as having been subsequently listed for cadaveric kidney transplantation.

80 n leukocyte antigen (HLA) mismatches (MM) in cadaveric kidney transplantation.

81 r 7614 HLA-matched and 81,364 HLA-mismatched cadaveric kidney transplantations reported to the UNOS S

82 en 75% to 90% at 1 year, approaching that of cadaveric kidney transplantations.

83 An increasing number of cadaveric kidney transplants are now performed with orga

84 sion analysis was conducted on 19246 primary cadaveric kidney transplants during 1995 to 1998.

85 age, > or =16 yr) recipients having solitary cadaveric kidney transplants from adult donors with vali

86 short-term graft survival rate of pediatric cadaveric kidney transplants has significantly improved,

87 The analysis included 60,827 cadaveric kidney transplants performed between 1988 and

88 All cadaveric kidney transplants performed between 1994 to 1

89 All patients were first cadaveric kidney transplants receiving the same maintena

90 s with immediate graft function (IGF) and 51 cadaveric kidney transplants were investigated for creat

91 Cadaveric kidney transplants with delayed graft function

92 nine, we reviewed our database of almost 500 cadaveric kidney transplants.

93 no significant difference between living and cadaveric kidney transplants.

94 ed with 33 matched adults who received adult cadaveric kidney transplants.

95 donors could increase the overall supply of cadaveric kidney transplants.

96 ased immunosuppression in patients receiving cadaveric kidney transplants.

97 The mean wait time of blood group O cadaveric kidney wait list candidates increases when the

98 exchanges will reduce the mean wait time for cadaveric kidney wait list candidates.

99 ill significantly shorten the wait times for cadaveric kidney wait list candidates.

100 A supply-to-demand model for the cadaveric kidney wait list estimated the mean wait time

101 rs), and the mean cold ischemia time for the cadaveric kidneys was 27.0+/-9.4 hr.

102 Perfusate of 26 transplanted cadaveric kidneys was analyzed; 19(73%) with IGF and 7(2

103 All cadaveric kidneys were preserved in University of Wiscon

104 -yr-old patient with a three-antigen-matched cadaveric kidney who received cyclosporine and anti-thym

105 andated the national sharing of well-matched cadaveric kidneys with payback to the national pool.

106 costs associated with the transplantation of cadaveric kidneys with various numbers of HLA mismatches